ProfTracy Robson

Professor Tracy Robson obtained her PhD in Molecular Radiation Science from Imperial College, London (1996). Her first academic post was as Lecturer in Radiation Science at Ulster University in 1997; she was promoted to Reader in 2001. She then moved to the School of Pharmacy, Queen’s University of Belfast in 2004 to take up the post of Reader in Molecular Pharmacology; she was promoted to Professor of Experimental Therapeutics in 2010. She joined RCSI as Professor and Head of Molecular & Cellular Therapeutics (MCT) in August 2016. She took over the position as Head of School of Pharmacy, RCSI, merging the School of Pharmacy with the Department of Molecular and Cellular Therapeutics to form a new school in 2019 which was renamed  as the School of Pharmacy and Biomolecular Sciences (PBS). In July 2024, she took on the role of Deputy Vice Chancellor for Academic Affairs, RCSI whilst still maintaining a research position within PBS.

 

She has a strong research track record in the biotherapeutics space, with a focus on cancer, obesity and inflammation which has been supported by ~€18 M of grant funding over the last 15 years from UK and Irish bodies. Her research has led to the development of a first-in-class drug, seven patents, and numerous original research publications in high impact journals. She has supervised 37 PhD students and was awarded the IACR Outstanding Contribution to Cancer Medicine and Research Award 2025